Understanding maternal immune responses affecting newborns with low platelet counts
Interrogating clinically relevant attributes of maternal alloimmunity in fetal/neonatal alloimmune thrombocytopenia
This study is looking at how a mother's immune system can affect her baby's platelets, which might lead to a serious bleeding condition in newborns, and it aims to find out which pregnancies are at higher risk so that better tests and prevention methods can be developed to help keep babies safe.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Versiti Wisconsin, INC. NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-11079524 on NIH RePORTER |
What this research studies
This research investigates how maternal immune responses to specific platelet proteins can lead to a serious condition in newborns called fetal/neonatal alloimmune thrombocytopenia (FNAIT). It aims to identify which pregnancies are at high risk for severe bleeding due to this condition by studying the interactions between maternal antibodies and fetal platelets. The research will utilize animal models to explore the underlying mechanisms and develop potential diagnostic tests and preventive strategies. By understanding these immune responses better, the research seeks to improve outcomes for affected infants.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant women who have previously had a child affected by fetal/neonatal alloimmune thrombocytopenia or those identified as at-risk for this condition.
Not a fit: Patients who are not pregnant or those whose pregnancies are not at risk for fetal/neonatal alloimmune thrombocytopenia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better identification and management of at-risk pregnancies, potentially preventing severe bleeding and associated complications in newborns.
How similar studies have performed: While the specific approach of this research is novel, similar studies have shown promise in understanding immune responses in pregnancy and their effects on newborn health.
Where this research is happening
Milwaukee, United States
- Versiti Wisconsin, INC. — Milwaukee, United States (Active)
Researchers
- Principal investigator: Newman, Debra Kay — Versiti Wisconsin, INC.
- Study coordinator: Newman, Debra Kay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.